HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Mass. toxicity warning bill

This article was originally published in The Rose Sheet

Executive Summary

Mass. toxicity warning bill: H 3188 is tabled following a March 30 hearing in the Natural Resources and Agriculture Committee with no further hearings scheduled to date. The measure would require the state department of public health to publish, by Sept. 1, 1996, a warning list of substances in consumer products known "to cause cancer or reproductive toxicity." The bill also would mandate that the state department of environmental protection identify health risks associated with each substance on the list by March 1, 1996. The Cosmetic, Toiletry and Fragrance association testified against H 3188 at the March 30 hearing, arguing that the bill would "undermine our current system for ensuring the safety of foods, drugs, cosmetics and medical devices" and would cause consumer confusion. H 3188 was introduced into the committee by Rep. Douglas Peterson (D-Marblehead) on Jan. 5...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS001497

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel